| Date & Time | 1-2 December 2026 |
|---|---|
| Location | Online |
A significant proportion of cancers remain unresponsive to immunotherapy, underscoring the need for strategies that deliver stronger immune activation. The challenge is that enhanced immunity to cancer is coupled to immune-related toxicities, mediated by T-cells attack on normal tissues due to failure of immune regulation. Addressing this challenge requires a systems-level understanding of how T-cells discriminate between self and non- self-antigens, and strategies to harness this knowledge to generate T-cells specific for cancer.
This brand-new EACR virtual conference will bring together leading basic and translational scientists to explore the mechanisms of T-cell antigen selectivity across multiple scales. It will be particularly relevant to researchers in immunology, cancer biology, cell therapy, systems biology, and machine learning, spanning early-career investigators through to established leaders in the field.
Submit your abstract by 19 October for a chance to have it included in our virtual poster presentation or be selected to present it as a Flash Talk or Proffered Paper. Registrations are open now until 16 November 2026.
More information and registration here.
